ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

ASCO Recognizes 15 for Leadership in Clinical Oncology, Updates Genetic Testing Recommendations

May 23, 2003

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

ECG Disputes Accrual Figures Cited By DeVita, Says Numbers Are Up 17% This Year And Still Rising

July 8, 1988

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

Rauscher Responds To Criticism

March 21, 1975